Joe Biden announced that he was going to nominate Dr. Robert Califf to head up the Food and Drug Administration(FDA).
President Joe Biden on Friday announced that he will nominate former Food and Drug Administration (FDA) Commissioner Dr. Robert Califf to once again head the agency.
Califf, who was commissioner for nearly a year starting in February 2016, “is one of the most experienced clinical trialists in the country, and has the experience and expertise to lead the Food and Drug Administration during a critical time in our nation’s fight to put an end to the coronavirus pandemic,†Biden said in a statement.
The post has been filled on a temporary basis by Dr. Janet Woodcock since the president entered office in January.
Several Democrats could oppose the nominee, considering three did the last time the Senate considered him.
The nominee could face an uphill battle, however.
Dem Senator Joe Manchin has already announced he will not support the nominee.
He cited Manchin’s ties to the pharmaceutical industry as to why.
Sen. Joe Manchin (D-W.Va.) said Friday that he opposes President Biden’s nominee for Food and Drug Administration (FDA) commissioner, Robert Califf, arguing he is not strong enough in fighting the opioid epidemic given his ties to the pharmaceutical industry.
“Dr. Califf’s nomination and his significant ties to the pharmaceutical industry take us backwards not forward,” Manchin said in a statement. “His nomination is an insult to the many families and individuals who have had their lives changed forever as a result of addiction.”
“I urge the Administration to nominate an FDA Commissioner that understands the gravity of the prescription drug epidemic and the role of the FDA in fighting back against the greed of the pharmaceutical industry,” he added.
The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions. You can help us beat Big Tech by following us on GETTR , Telegram, and Rumble.
